ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1205 • 2016 ACR/ARHP Annual Meeting

    In silico Drug Repurposing Analysis Supports Phosphoinositol 3 Kinase Inhibitors As Treatment of LUPUS

    Daniel Toro1, Pedro Carmona Sanz2 and Marta Alarcón-Riquelme3,4, 1Bioinformatics and Medical Genomics, Center for Genomics and Oncological Research (GENYO), Pfizer-University of Granada-Andalusian Regional Government, Health Sciences Technology Park, Ganada, Spain, 2Unit of Bioinformatics, Center for Genomics and Oncological Research (GENYO), Pfizer-University of Granada-Andalusian Regional Government, Health Sciences Technology Park, Granada, Spain, 3Center for Genomics and Oncological Research (GENYO), Pfizer-University of Granada-Andalusian Regional Government, Health Sciences Technology Park, Granada, Spain, 4Unit for Chronic Inflammatory Diseases, Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a clinically heterogeneous disease with few treatment options. Current treatments are not fully effective and show highly variable responses.…
  • Abstract Number: 1206 • 2016 ACR/ARHP Annual Meeting

    A Replication Study and Meta-Analysis Demonstrate the Influence of the mtDNA Haplogroups in the Rate of Incident Knee Osteoarthritis. Functional Explanation of This Association Using Transmitochondrial Cybrids

    Ignacio Rego-Pérez1, Mercedes Fernandez Moreno1, Angel Soto-Hermida1, Maria Eugenia Vazquez Mosquera1, Estefanía Cortés-Pereira1, Sara Relaño-Fernandez2, Tamara Hermida-Gómez3, Sonia Pertega4, Rafael Garesse5, Natividad Oreiro3, Carlos Fernandez-Lopez1 and Francisco J. Blanco1,6, 1Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo HospitalarioUniversitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 2Plataforma de Genómica. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 3Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 4Unidad de Epidemiología Clínica y Bioestadística. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 5Departamento de Bioquímica, Instituto de Investigaciones Biomédicas "Alberto Sols" UAM-CSIC y Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidad Autónoma de Madrid 28029, Madrid, Spain, Madrid, Spain, 6Rheumatology Division, INIBIC-Complejo Hospitalario Universitario A Coruña (CHUAC), La Coruña, Spain

    Background/Purpose: The study of the mitochondria in the context of osteoarthritis (OA) attracted much attention. In this study we aimed to evaluate the influence of…
  • Abstract Number: 1207 • 2016 ACR/ARHP Annual Meeting

    Design of a Multiplex Serum Proteome Assay to Monitor Biologic Drug Response in Rheumatoid Arthritis Patients

    Niamh Callan1, Aisha Butt1, Stephen R. Pennington2, Cathy McGeough3, Philip Gardiner4, Gary Wright5, Tony Bjourson3 and David S. Gibson6, 1Proteome Research Centre, Conway Institute, University College Dublin, Dublin, Ireland, 2Proteome Research Centre, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland, 3Northern Ireland Centre for Stratified Medicine, Ulster University, Londonderry, United Kingdom, 4Rheumatology, Altnagelvin Hospital, Londonderry, United Kingdom, 5Rheumatology, Musgrave Park Hospital, BELFAST, United Kingdom, 6Inflammatory Disease Research Group, Northern ireland Centre for Stratified Medicine, Ulster University, Londonderry, United Kingdom

    Background/Purpose: Biologic drugs have revolutionised the treatment of Rheumatoid Arthritis (RA), however these therapies are expensive and exhibit a high non–response rate (30%). Currently there…
  • Abstract Number: 1208 • 2016 ACR/ARHP Annual Meeting

    High-Throughput Screening Discovers Multiple Novel Autoantibodies in Rheumatoid Arthritis, Systemic Lupus, Systemic Sclerosis and Sjogrens Syndrome

    Peter Schulz-Knappe1, Hans-Dieter Zucht1, Petra Budde1, Heike Göhler1, Daniel Wirtz1, Johannes Schulte-Pelkum1, Stefan Vordenbäumen2, Torsten Witte3 and Prof. Dr. Matthias Schneider4, 1Protagen AG, Dortmund, Germany, 2Rheumatology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany, 3Department of Clinical Immunology and Rheumatology, Hannover Medical School, Hannover, Germany, 4Department of Rheumatology & Hiller Research Unit, Heinrich-Heine University, Düsseldorf, Germany

    Background/Purpose: Diagnostic biomarkers are decision-making tools in clinical lab routine and are of growing importance for clinical management of patients. In autoimmune diseases, one important…
  • Abstract Number: 1209 • 2016 ACR/ARHP Annual Meeting

    Sporadic Hemophagocytic Lymphohistiocytosis (sHLH): A Polygenic Disease? a Report of French National,  Prospective, Cohort of 205 Patients

    Coralie Bloch-Queyrat1,2, Jean Philippe Jais3, Marine Gil4, Brigitte Bader-Meunier5, Olivier Hermine6,7 and Genevieve de Saint-Basile4, 1Clinical Research Unit, University Hospital Paris Seine Saint Denis, AP-HP, Bobigny, France, 2Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications INSERM U 1163 / CNRS ERL 8254 Institut IMAGINE, Paris, paris, France, 3Biostatstical Departement, Department of biostatistics Necker Enfants Malades Hospital, AP-HP, Paris, France, 4Normal and pathological homeostasis of the immune system laboratory Institut IMAGINE Paris, Paris, France, 5Pediatric Rheumatology & Immunology, Pediatric Rheumatology & Immunology, Necker hospital, Imagine Institution, Paris, France, 6Department of Hematology, Hôpital Necker, Paris, France, 7Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications INSERM U 1163 / CNRS ERL 8254 Labex on Red cell and iron metabolism Institut IMAGINE, Paris, France

    Background/Purpose: The role of genetic factors in the occurrence and/or severity of sHLH is not yet known. Therefore, from 2010 to 2016, we performed a…
  • Abstract Number: 1210 • 2016 ACR/ARHP Annual Meeting

    A Genome-Wide Association Study of Psoriatic Arthritis in Italian Population

    Mariagrazia Catanoso1, Pierluigi Macchioni1, Salvatore D'Angelo2, Antonio Marchesoni3, Roberta Ramonda4, Alberto Cauli5, Fabio Massimo Perrotta6, Roberto Bortolotti7, Guseppe Provenzano8, Giovanni Pistone9, Katya Boito10, Cristina Giuliani11, Paolo Garagnani11, Davide Gentilini12, Mariana Lofrano13, Laura Rotunno14, Mariagrazia Lorenzin15, Ignazio Olivieri13, Alessandro Mathieu16, Guido Valesini17, Giuseppe Paolazzi7, Roberto Baricchi18, Anna Maria Di Blasio12, Luigi Boiardi19, Claudio Franceschi20 and Carlo Salvarani1, 1Rheumatology Unit, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 2Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, matera, Italy, 3Rheumatology Unit, Orthopedic Institute G. Pini, Milano, Italy, 4Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy, 5University of Cagliari, Cagliari, Italy, 6Rheumatology Unit, Sapienza University, Department of Internal Medicine and Medical Specialties, Roma, Italy, 7Rheumatology Unit, Santa Chiara Hospital, Trento, Italy, 8Reumatology Unit, Villa Sofia-CTO Hospital, Palermo, Italy, 9Rheumatology Unit, ARNAS Civico, Di Cristina e Benfratelli Hospital, Palermo, Italy, 10Transfusion Medicine Unit,, Arcispedale S. Maria Nuova, IRCCS, Reggio Emilia, Italy, 11Laboratory of Molecular Anthropology, Centre for Genome Biology University, Bologna, Italy, 12Laboratory of Molecular Biology, Istituto Auxologico Italiano, IRCCS, Milano, Italy, 13Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Matera, Italy, 14Orthopedic Institute G.Pini, Rheumatology Unit, Milano, Italy, 15Department of Medicine, University of Padova - Rheumatology Unit, Padova, Italy, 16Department of Medical Sciences, Rheumatology Unit - University of Cagliari, Cagliari, Italy, 17Internal Medicine and Medical Specialties Department, Policlinico Umberto I, La Sapienza University of Rome, Roma, Italy, 18Transfusion Medicine Unit, IRCCS S. Maria Nuova Hospital, Reggio Emilia, Italy, 19Rheumatology Unit, Arcispedale S.Maria Nuova, IRCCS, Reggio Emilia, Italy, 20Laboratory of Molecular Anthropology & Centre for Genome Biology University of Bologna, Bologna, Italy

    rexm-rs12191877 (p=4.87 x10-10, OR 1.731, 95%CI =1.46-2.06), exm-rs4947248 (p=1.98 x10-9 , OR 1.56, 95%CI = 1.35-1.80). Moreover, in PsA patients we identified signals of association…
  • Abstract Number: 1211 • 2016 ACR/ARHP Annual Meeting

    Allele-Dependent Binding of a Viral Protein to Autoimmune Disease-Associated Genetic Variants

    Matthew T. Weirauch1, Daniel Miller1, Leah C. Kottyan2, Ignacio Ibarra3, Sayeed Syed4, Xiaoting Chen1, Erin Zoller1, Arthur Lynch1, Connor Schroeder1, Josh Lee1, Albert Magnussen1, Ally Yang5, Timothy R. Hughes5, Joo-Seop Park1, Charles Vinson4 and John B. Harley6,7, 1Cincinnati Childrens Hospital, Cincinnati, OH, 2Center for Autoimmune Genomics and Etiology, Cincinnati Childrens Hospital, Cincinnati, OH, 3EMBL, Heidelberg, Germany, 4NCI, Bethesda, MD, 5University of Toronto, Toronto, ON, Canada, 6US Department of Veterans Affairs Medical Center, Cincinnati, OH, 7Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Childrens Hospital, Cincinnati, OH

    Methods: We tested the hypothesis that some autoimmune variants might act by altering the binding of the EBV-encoded transcription factor ZTA, consequently resulting in downstream…
  • Abstract Number: 1212 • 2016 ACR/ARHP Annual Meeting

    A Combined Large Scale Meta-Analysis Identifies COG6 As a Novel Shared Risk Locus for Rheumatoid Arthritis and Systemic Lupus Erythematosus

    Ana Márquez1, Laura Vidal-Bralo2, Luis Rodriguez-Rodriguez3, Miguel Angel González-Gay4, Alejandro Balsa5, Isidoro Gonzalez-Alvaro6, Patricia Carreira7, Norberto Ortego Centeno8, Maria del Mar Ayala Gutierrez9, Francisco José García-Hernández10, Francisca González Escribano11, José Mario Sabio12, Carles Tolosa13, Ana Suárez14, Antonio Gonzalez15, Leonid Padyukov16, Jane Worthington17, Timothy J. Vyse18,19, Marta E. Alarcon Riquelme20,21 and Javier Martín1, 1Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, PTS-Granada, Granada, Spain, 2Instituto Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain, 3Rheumatology Department and Heath Research Institute (IdISSC), Hospital Clinico San Carlos, Madrid, Spain, 4Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, Santander, Spain, 5Department of Rheumatology and Institute for Health Research (IdiPAZ), University Hospital La Paz, Madrid, Spain, 6Rheumatology, Rheumatology Service, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 7Department of Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, 8Systemic Autoimmune Diseases Unit, Hospital Clínico San Cecilio, Granada, Spain, 9Department of Internal Medicine, Hospital Carlos Haya, Málaga, Spain, 10Department of Internal Medicine, Hospital Universitario Virgen del Rocío, Sevilla, Spain, 11Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, Spain, 12Department of Internal Medicine, Hospital Virgen de las Nieves, Granada, Spain, 13Department of Internal Medicine, Hospital Parc Taulí, Sabadell, Spain, 14Department of Functional Biology, Immunology Area, Faculty of Medicine, University of Oviedo, Oviedo, Spain, 15Laboratorio de Investigación 10 and Rheumatology Unit, Instituto de Investigación Sanitaria - Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain, 16Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 17Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 18Department of Medical and Molecular Genetics, King's College London, London, United Kingdom, 19Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, United Kingdom, 20Centro de Genómica e Investigación Oncológica (GENYO), Pfizer-Universidad de Granada-Junta de Andalucía, Granada, Spain, 21Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: One of the main limitations of the association studies in autoimmunity is the difficulty in identifying genetic risk variants with modest effects, given the…
  • Abstract Number: 1213 • 2016 ACR/ARHP Annual Meeting

    Targeted Next-Generation Sequencing of 128 Genes Associated with Rheumatoid Arthritis

    Khai Pang Leong1, Liuh Ling Goh2, Edward Yu Wing Chee2, Petrina Pei Qin Lim2, Grace Li-Xian Toh2, Ee Tzun Koh3 and Tan Tock Seng Hospital Rheumatoid Arthritis Study Group, 1Rheumatology/Allerg/Immunology, Tan Tock Seng Hospital, Singapore, Singapore, 2Clinical Research & Innovation Office, Tan Tock Seng Hospital, Singapore, Singapore, 3Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore

    Background/Purpose: Through genome-wide association scans (GWAS), more than 120 genes have been found to be associated with rheumatoid arthritis (RA). This study aims to search…
  • Abstract Number: 1214 • 2016 ACR/ARHP Annual Meeting

    Autoantibody Reactivities Correlated with SLE Disease Activity Identified By the SLE-key® iCHIP® Platform

    Chaim Putterman1, Pennina Safer2, Keren Jakobi2, Rachel Sorek2, Ilana Gilkaite2, Kyle Ferber3, Steve Wallace3, Amanda Harris Altice3, D. Scott Batty3 and Irun R Cohen2,4, 1Albert Einstein College of Medicine, Bronx, NY, 2ImmunArray LTD, Rehovot, Israel, 3ImmunArray Inc., Richmond, VA, 4Immunology, Weizmann Institute of Science, Rehovot, Israel

    Background/Purpose: We have developed an antigen microarray technology to study antibody profiles to elucidate and diagnose clinical states of SLE patients – the iCHIP® SLE-key®…
  • Abstract Number: 1215 • 2016 ACR/ARHP Annual Meeting

    Interferon Signature Genes Are Differentially Expressed Between Microscopic Polyangiitis and Systemic Lupus Erythematosus Peripheral Blood Transcriptomes

    Aya Kawasaki1, Daisuke Tsukui2, Yuya Kondo3, Yoshitaka Kimura2, Kurumi Asako2, Hiroshi Furukawa1, Hajime Kono2, Takayuki Sumida4 and Naoyuki Tsuchiya1, 1Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan, 3Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, 4Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

    Background/Purpose:  Interferon (IFN) signature has been established in the peripheral blood of the patients with systemic lupus erythematosus (SLE) by transcriptome analyses, indicating a role…
  • Abstract Number: 1216 • 2016 ACR/ARHP Annual Meeting

    Sjogren’s Syndrome-Associated Transcripts Show Correlation with Objective Measures of Dryness

    John A. Ice1, Indra Adrianto1, Astrid Rasmussen1, Kiely Grundahl2, Michelle L. Joachims3, Graham B. Wiley1, Jennifer A. Kelly1, Glen D. Houston4, David M. Lewis4, Lida Radfar5, Donald U. Stone6,7, Barbara M. Segal8, Nelson L. Rhodus9, Joel M. Guthridge3, James Chodosh10,11, Raj Gopalakrishnan12, Andrew J.W. Huang13, Pamela J Hughes14, Michael D. Rohrer15, Judith A. James1,16,17, Courtney G. Montgomery1, R. Hal Scofield1,17,18, Patrick Gaffney1, Kathy L. Sivils3 and Christopher J. Lessard1, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 5Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 6King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, 7Department of Ophthalmology, Johns Hopkins University, Baltimore, MD, 8Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 9Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 10Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 11Harvard Medical School, Boston, MA, 12Diagnostic and Biological Sciences, Division of Oral Pathology, University of Minnesota School of Dentistry, Minneapolis, MN, 13Department of Ophthalmology and Visual Sciences, Washington University, St. Louis, MO, 14Department of Oral and Maxillofacial Surgery, Oregon Health & Science University School of Dentistry, Portland, OR, 15Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, MN, 16Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 17Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 18US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is a chronic autoimmune disorder in which exocrine dysfunction can lead to chronic, debilitating dryness. Expression studies in SS have identified…
  • Abstract Number: 1217 • 2016 ACR/ARHP Annual Meeting

    Identification of Sjogren’s Syndrome-Associated Long Non-Coding RNAs That Are Co-Expressed with Key Protein-Coding Transcripts Involved in Dysregulated Interferon Responses

    John A. Ice1, Indra Adrianto1, Michelle L. Joachims2, Jennifer A. Kelly2, Graham B. Wiley1, Astrid Rasmussen1, Kiely Grundahl3, Glen D. Houston4, David M. Lewis4, Lida Radfar5, Donald U. Stone6,7, Joel M. Guthridge2, Barbara M. Segal8, Nelson L. Rhodus9, James Chodosh10,11, Raj Gopalakrishnan12, Andrew J.W. Huang13, Pamela J Hughes14, Michael D. Rohrer15, Judith A. James16,17,18, Courtney G. Montgomery1, R. Hal Scofield1,18,19, Patrick Gaffney1, Kathy L. Sivils2,16 and Christopher J. Lessard1,16, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 5Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 6King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, 7Department of Ophthalmology, Johns Hopkins University, Baltimore, MD, 8Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 9Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 10Harvard Medical School, Boston, MA, 11Massachusetts Eye and Ear Infirmary, Boston, MA, 12Diagnostic and Biological Sciences, Division of Oral Pathology, University of Minnesota School of Dentistry, Minneapolis, MN, 13Department of Ophthalmology and Visual Sciences, Washington University, St. Louis, MO, 14Department of Oral and Maxillofacial Surgery, Oregon Health & Science University School of Dentistry, Portland, OR, 15Hard Tissue Research Laboratory, University of Minnesota School of Dentistry, Minneapolis, MN, 16Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 17Clinical Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 18Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 19US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: The “interferon signature”, marked by transcriptional upregulation of interferon (IFN)-inducible (IFI) genes, is a common finding in Sjögren’s syndrome (SS) that is associated with…
  • Abstract Number: 1218 • 2016 ACR/ARHP Annual Meeting

    Extensive Genetic Overlap of Traits Related to Gout, Hyperuricemia and Its Comorbidities

    Richard J. Reynolds1, Marguerite Irvin2, Gustavo de los Campos3, Hwasoon Kim3, Jasvinder Singh4 and Ana Vazquez3, 1Medicine, University of Alabama at Birmingham, Birmingham, AL, 2Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 3Michigan State University, East Lansing, MI, 4University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose:  Gout and hyperuricemia (serum urate > 7 mg/dL) typically present in the context of one or more comorbidities including type-2 diabetes, chronic renal disease,…
  • Abstract Number: 1219 • 2016 ACR/ARHP Annual Meeting

    Differential Peripheral Blood DNA Methylation Patterns Are Predictive of Radiographic OA Progression

    Matlock A. Jeffries1, Madison Andrews2, Judith A. James3, Mary Beth Humphrey4 and Amr H. Sawalha5, 1Rheumatology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Medicine/Rheumatology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5Division of Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Extensive evidence has correlated epigenetic alterations in articular tissues with both the presence and progression of human osteoarthritis, but data regarding extraarticular tissues are…
  • « Previous Page
  • 1
  • …
  • 1496
  • 1497
  • 1498
  • 1499
  • 1500
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology